Biomol Ther.  2016 May;24(3):291-297. 10.4062/biomolther.2015.113.

Cytisine, a Partial Agonist of α4β2 Nicotinic Acetylcholine Receptors, Reduced Unpredictable Chronic Mild Stress-Induced Depression-Like Behaviors

Affiliations
  • 1Department of Pharmacology, School of Pharmacy, The Fourth Military Medical University, Xi'an 710032, China. liushb1974@aliyun.com
  • 2Department of Orthopedics, Jinling Hospital, Clinical School of Nanjing, Second Military Medical University, Nanjing 210002, China.

Abstract

Cytisine (CYT), a partial agonist of α4β2-nicotinic receptors, has been used for antidepressant efficacy in several tests. Nicotinic receptors have been shown to be closely associated with depression. However, little is known about the effects of CYT on the depression. In the present study, a mouse model of depression, the unpredictable chronic mild stress (UCMS), was used to evaluate the activities of CYT. UCMS caused significant depression-like behaviors, as shown by the decrease of total distances in open field test, and the prolonged duration of immobility in tail suspension test and forced swimming test. Treatment with CYT for two weeks notably relieved the depression-like behaviors in the UCMS mice. Next, proteins related to depressive disorder in the brain region of hippocampus and amygdala were analyzed to elucidate the underlying mechanisms of CYT. CYT significantly reversed the decreases of 5-HT1A, BDNF, and mTOR levels in the hippocampus and amygdala. These results imply that CYT may act as a potential anti-depressant in the animals under chronic stress.

Keyword

Cytisine; Depression; Nicotinic receptor; Chronic stress

MeSH Terms

Amygdala
Animals
Brain
Brain-Derived Neurotrophic Factor
Depression
Depressive Disorder
Hindlimb Suspension
Hippocampus
Mice
Physical Exertion
Receptors, Nicotinic*
Brain-Derived Neurotrophic Factor
Receptors, Nicotinic
Full Text Links
  • BT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr